1. Academic Validation
  2. Circulating mitochondrial N-formyl peptides contribute to secondary nosocomial infection in patients with septic shock

Circulating mitochondrial N-formyl peptides contribute to secondary nosocomial infection in patients with septic shock

  • Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):e2018538118. doi: 10.1073/pnas.2018538118.
Woon Yong Kwon 1 2 Gil Joon Suh 3 2 Yoon Sun Jung 2 Seung Min Park 4 Subi Oh 4 Sung Hee Kim 2 A Rum Lee 2 Jeong Yeon Kim 2 Hayoung Kim 2 Kyung Ah Kim 5 Young Kim 5 Byoung Choul Kim 5 6 Taegyun Kim 2 Kyung Su Kim 2 Kiyoshi Itagaki 7 Carl J Hauser 7
Affiliations

Affiliations

  • 1 Department of Emergency Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; kwy711@hanmail.net.
  • 2 Department of Emergency Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • 3 Department of Emergency Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • 4 Department of Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • 5 Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
  • 6 Division of Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
  • 7 Department of Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA 02215.
Abstract

Secondary infections typically worsen outcomes of patients recovering from septic shock. Neutrophil [polymorphonuclear leukocytes (PMNs)] migration to secondarily inoculated sites may play a key role in inhibiting progression from local Bacterial inoculation to secondary Infection. Mitochondrial N-formyl peptide (mtFP) occupancy of formyl peptide receptor-1 (FPR1) has been shown to suppress PMN chemotaxis. Therefore, we studied the association between circulating mtFPs and the development of secondary Infection in patients with septic shock. We collected clinical data and plasma samples from patients with septic shock admitted to the intensive care unit for longer than 72 h. Impacts of circulating nicotinamide adenine dinucleotide dehydrogenase subunit-6 (ND6) upon clinical outcomes were analyzed. Next, the role of ND6 in PMN chemotaxis was investigated using isolated human PMNs. Studying plasma samples from 97 patients with septic shock, we found that circulating ND6 levels at admission were independently and highly associated with the development of secondary Infection (odds ratio = 30.317, 95% CI: 2.904 to 316.407, P = 0.004) and increased 90-d mortality (odds ratio = 1.572, 95% CI: 1.002 to 2.465, P = 0.049). In ex vivo experiments, ND6 pretreatment suppressed FPR1-mediated PMN chemotactic responses to Bacterial peptides in the presence of multiple cytokines and chemokines, despite increased nondirectional PMN movements. Circulating mtFPs appear to contribute to the development of secondary Infection and increased mortality in patients with septic shock who survive their early hyperinflammatory phase. The increased susceptibility to secondary Infection is probably partly mediated by the suppression of FPR1-mediated PMN chemotaxis to secondary infected sites.

Keywords

formyl peptide; infections; neutrophils; nosocomial; sepsis.

Figures
Products